中华核医学杂志
中華覈醫學雜誌
중화핵의학잡지
CHINESE JOURNAL OF NUCLEAR MEDICINE
2009年
3期
171-173
,共3页
刘松涛%柳澄%姚树展%韩广秀%黄葵红%宁国庆%李昕
劉鬆濤%柳澄%姚樹展%韓廣秀%黃葵紅%寧國慶%李昕
류송도%류징%요수전%한엄수%황규홍%저국경%리흔
胸膜肿瘤%体层摄影术,发射型计算机%体层摄影术,X线计算机%脱氧葡萄糖
胸膜腫瘤%體層攝影術,髮射型計算機%體層攝影術,X線計算機%脫氧葡萄糖
흉막종류%체층섭영술,발사형계산궤%체층섭영술,X선계산궤%탈양포도당
Pleural neoplasms%Tomography,emission-computed%Tomography,X-ray computed%Deoxyglucose
目的 探讨18F-脱氧葡萄糖(FDG)PET/CT显像在恶性胸膜间皮瘤(MPM)诊断中的临床价值及原发肿瘤病灶平均标准摄取值(SUVmax)对患者预后的判断价值.方法 回顾性总结17例2002-2008年临床疑诊MPM患者18F-FDG PET/CT显像资料,测量病灶的SUVmax.将病理检查及临床随访证实的MPM患者按照有无转移分为2组,测定每例患者原发肿瘤病灶的SUVmax,用受试者工作特征(ROC)曲线评价SUVmax对患者转移与否的诊断价值,判断预后.采用SPSS 11.0软件进行t检验.结果 经病理及随访结果证实MPM 12例,良性胸膜病变5例,二者的SUVmax分别为5.78±1.81和2.72±2.51,差异有统计学意义(t=2.8,P<0.05).全身18F-FDG PET/CT显像诊断MPM的灵敏度为100%(12/12),特异性为4/5,准确性为94%(16/17),18F-FDG PET/CT显像有7例MPM伴有骨和(或)淋巴结转移.SUVmaxROC曲线分析表明曲线下面积(AUC)为0.80.结论 全身18F-FDG PET/CT显像对于MPM的诊断有重要价值.原发肿瘤病灶SUVmax越高越易发生转移,预后越差.
目的 探討18F-脫氧葡萄糖(FDG)PET/CT顯像在噁性胸膜間皮瘤(MPM)診斷中的臨床價值及原髮腫瘤病竈平均標準攝取值(SUVmax)對患者預後的判斷價值.方法 迴顧性總結17例2002-2008年臨床疑診MPM患者18F-FDG PET/CT顯像資料,測量病竈的SUVmax.將病理檢查及臨床隨訪證實的MPM患者按照有無轉移分為2組,測定每例患者原髮腫瘤病竈的SUVmax,用受試者工作特徵(ROC)麯線評價SUVmax對患者轉移與否的診斷價值,判斷預後.採用SPSS 11.0軟件進行t檢驗.結果 經病理及隨訪結果證實MPM 12例,良性胸膜病變5例,二者的SUVmax分彆為5.78±1.81和2.72±2.51,差異有統計學意義(t=2.8,P<0.05).全身18F-FDG PET/CT顯像診斷MPM的靈敏度為100%(12/12),特異性為4/5,準確性為94%(16/17),18F-FDG PET/CT顯像有7例MPM伴有骨和(或)淋巴結轉移.SUVmaxROC麯線分析錶明麯線下麵積(AUC)為0.80.結論 全身18F-FDG PET/CT顯像對于MPM的診斷有重要價值.原髮腫瘤病竈SUVmax越高越易髮生轉移,預後越差.
목적 탐토18F-탈양포도당(FDG)PET/CT현상재악성흉막간피류(MPM)진단중적림상개치급원발종류병조평균표준섭취치(SUVmax)대환자예후적판단개치.방법 회고성총결17례2002-2008년림상의진MPM환자18F-FDG PET/CT현상자료,측량병조적SUVmax.장병리검사급림상수방증실적MPM환자안조유무전이분위2조,측정매례환자원발종류병조적SUVmax,용수시자공작특정(ROC)곡선평개SUVmax대환자전이여부적진단개치,판단예후.채용SPSS 11.0연건진행t검험.결과 경병리급수방결과증실MPM 12례,량성흉막병변5례,이자적SUVmax분별위5.78±1.81화2.72±2.51,차이유통계학의의(t=2.8,P<0.05).전신18F-FDG PET/CT현상진단MPM적령민도위100%(12/12),특이성위4/5,준학성위94%(16/17),18F-FDG PET/CT현상유7례MPM반유골화(혹)림파결전이.SUVmaxROC곡선분석표명곡선하면적(AUC)위0.80.결론 전신18F-FDG PET/CT현상대우MPM적진단유중요개치.원발종류병조SUVmax월고월역발생전이,예후월차.
Objective Malignant pleural mesothelioma (MPM) is an uncommon neoplasm arising from mesothelial cells of the pleura. The prognosis is poor with median survival of 4- 12 months. The aim of this study was to evaluate the clinic value of 18F-fluorodeoxyglucose (FDG) PET/CT imaging in the diagno-sis and to staging of MPM and to determine if the mean standardized uptake value (SUVmax) of primary tumor correlates with staging and prognosis. Methods Study was conducted retrospectively including 17 pa-tients with clinical suspicion of MPM from 2002 to 2008. Twelve cases of MPM and 5 cases benign pleural pa-thology were proven by histopathology and clinical follow-up. 18F-FDG PET/CT imaging was performed 1 h af-ter injection of 7.4 MBq/kg 18F-FDG. Patients with MPM confirmed by histopatholagy were divided into two groups: with and without metastasis. PET/CT findings were analyzed to determine if SUVmax of primary tumor correlates with staging and prognosis. Receiver operating characteristic (ROC) curve of SUVmax of primary tumor was evaluated to determine if it was a predictor of metastasis and survival time. Results The difference in SUVmax between MPM and benign pleural were statistical significant (5.78±1.81 vs 2.72± 2.51, t = 2. 8, P < 0.05). The diagnostic sensitivity, specificity and accuracy of 18F-FDG PET/CT imaging for MPM were 100% (12/12) , 4/5 and 94% (16/17). All 7 cases of bone and lymph node metastases were detected by 18F-FDG PET/CT imaging. Area under the curve (AUC) was 0.80. Conclusions 18F-FDG PET/CT imaging is useful in the diagnosis and staging of MPM. High SUVmax in the primary tumor correlates well with prognosis and predication of a greater propensity to have nodal and distant metastasis.